Dopamine and the regulation of cognition and attention
- PMID: 12126656
- DOI: 10.1016/s0301-0082(02)00011-4
Dopamine and the regulation of cognition and attention
Abstract
Dopamine (DA) acts as a key neurotransmitter in the brain. Numerous studies have shown its regulatory role for motor and limbic functions. However, in the early stages of Parkinson's disease (PD), alterations of executive functions also suggest a role for DA in regulating cognitive functions. Some other diseases, which can also involve DA dysfunction, such as schizophrenia or attention deficit hyperactivity disorder (ADHD) in children, as shown from the ameliorative action of dopaminergic antagonists and agonists, respectively, also show alteration of cognitive functions. Experimental studies showed that selective lesions of the dopaminergic neurons in rats or primates can actually provide cognitive deficits, especially when the mesocorticolimbic component of the dopaminergic systems is altered. Data from the experiments also showed significant alteration in attentional processes, thus raising the question of direct involvement of DA in regulating attention. Since the dopaminergic influence is mainly exerted over the frontal lobe and basal ganglia, it has been suggested that cognitive deficits express alteration in these subcortical brain structures closely linked to cortical areas, more than simple deficit in dopaminergic transmission. This point is still a matter of debate but, undoubtedly, DA acts as a powerful regulator of different aspects of cognitive brain functions. In this respect, normalizing DA transmission will contribute to improve the cognitive deficits not only related to neurologic or psychiatric diseases, but also in normal aging. Ontogenic and phylogenetic analysis of dopaminergic systems can provide evidences for a role of DA in the development of cognitive general capacities. DA can have a trophic action during maturation, which may influence the later cortical specification, particularly of pre-frontal cortical areas. Moreover, the characteristic extension of the dopaminergic cortical innervation in the rostro-caudal direction during the last stages of evolution in mammals can also be related to the appearance of progressively more developed cognitive capacities. Such an extension of cortical DA innervation could be related to increased processing of cortical information through basal ganglia, either during the course of evolution or development. DA has thus to be considered as a key neuroregulator which contributes to behavioral adaptation and to anticipatory processes necessary for preparing voluntary action consequent upon intention. All together, it can be suggested that a correlation exists between DA innervation and expression of cognitive capacities. Altering the dopaminergic transmission could, therefore, contribute to cognitive impairment.
Copyright 2002 Elsevier Science Ltd.
Similar articles
-
Dopamine: a key regulator to adapt action, emotion, motivation and cognition.Curr Opin Neurol. 2003 Dec;16 Suppl 2:S3-9. Curr Opin Neurol. 2003. PMID: 15129844 Review.
-
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.Neurotox Res. 2006 Dec;10(3-4):167-79. doi: 10.1007/BF03033354. Neurotox Res. 2006. PMID: 17197367 Review.
-
Dopaminergic contribution to the regulation of emotional perception.Clin Neuropharmacol. 2005 Sep-Oct;28(5):228-37. doi: 10.1097/01.wnf.0000185824.57690.f0. Clin Neuropharmacol. 2005. PMID: 16239763 Review.
-
Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.Mov Disord. 2008;23 Suppl 3:S560-9. doi: 10.1002/mds.22020. Mov Disord. 2008. PMID: 18781673 Review.
-
Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease.Neurodegener Dis. 2013;11(2):102-11. doi: 10.1159/000341999. Epub 2012 Nov 1. Neurodegener Dis. 2013. PMID: 23128796
Cited by
-
Nanoplasmonic aptasensor for sensitive, selective, and real-time detection of dopamine from unprocessed whole blood.Sci Adv. 2024 Sep 6;10(36):eadp7460. doi: 10.1126/sciadv.adp7460. Epub 2024 Sep 4. Sci Adv. 2024. PMID: 39231221 Free PMC article.
-
Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System.Medicina (Kaunas). 2024 Jun 23;60(7):1028. doi: 10.3390/medicina60071028. Medicina (Kaunas). 2024. PMID: 39064457 Free PMC article.
-
The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis.Sleep Adv. 2024 Jun 26;5(1):zpae043. doi: 10.1093/sleepadvances/zpae043. eCollection 2024. Sleep Adv. 2024. PMID: 39036743 Free PMC article.
-
Differential effects of self-administered cocaine in adolescent and adult rats on stimulus-reward learning.Psychopharmacology (Berl). 2007 Oct;194(3):403-11. doi: 10.1007/s00213-007-0852-6. Epub 2007 Jul 5. Psychopharmacology (Berl). 2007. PMID: 17609932
-
Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls.Biol Psychiatry. 2008 Jan 1;63(1):72-9. doi: 10.1016/j.biopsych.2007.03.031. Epub 2007 Aug 20. Biol Psychiatry. 2008. PMID: 17707347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical